Free tool · no sign-up

Equity Curve Simulator

Enter win rate, risk-reward and risk per trade: see hundreds of possible paths for your capital and the drawdown you should expect.

Inputs

USD
Currency
%
R
%
Risk basis
Paths
Costs and simulation settings
USD
%
Median final equityUS$13,613.77
Median maximum drawdown7.74%
Losing paths0.6%
10k12.5k15k17.5k0255075100
MedianStarting capitalUSD · 100 trades · 60 paths
Full simulation statistics

Results across all paths

Mean final equity
US$14,009.26
Median final equity
US$13,613.77
Final equity · 10th percentile
US$11,381.21
Final equity · 90th percentile
US$16,777.73
Lowest final equity
US$9,514.78
Highest final equity
US$21,303.61
Maximum drawdown · median
7.74%
Maximum drawdown · mean
8.1%
Worst drawdown
24.55%
Paths with drawdown ≥ 20%
0.2%
Losing paths
0.6%
Paths reaching zero
0%
Longest losing streak
24 trades
Gross expectancy
0.35 R

500 paths × 100 trades · Win rate 45% · 2 R · Risk 1% of current balance · Cost US$0.00/trade · Seed 42

The model generates independent wins and losses using constant inputs. These statistics describe hypothetical paths, not future strategy performance.

How it works

  1. Step 1

    Enter your strategy

    Win rate, average win to average loss, risk per trade and number of trades. If you know them, add your average costs per trade too.

  2. Step 2

    Explore the scenarios

    The simulator generates up to 1,000 random sequences with the same rules. The purple line is the median: half the scenarios end above it, half below.

  3. Step 3

    Read the risk, not just the return

    Check drawdown, losing streaks and the chance of ending at a loss. Even a winning strategy can go through long, difficult stretches.

FAQ

Frequently asked questions

  1. No. It shows what can happen if win rate and risk-reward stay as entered. If the market or your execution changes, so do the results.

Can’t find your answer? Write to the team

Each tool answers one clear question.

From calculations to real data.

Test your strategy in the Backtester and measure real results in the Journal.